State of the Art Paper the Role of Nateglinide and Repaglinide, Derivatives of Meglitinide, in the Treatment of Type 2 Diabetes Mellitus

Archives of Medical Science - Poland
doi 10.5114/aoms.2013.34991
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Efficacy and Safety of Repaglinide vs Nateglinide for Treatment of Japanese Patients With Type 2 Diabetes Mellitus

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2011English

State of the Art Paper Tuberculosis and Diabetes Mellitus – An Underappreciated Association

Archives of Medical Science
Medicine
2014English

Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-Of-The-Art Review

Mayo Clinic Proceedings
Medicine
2018English

The Role of MTNR1B Genetic Polymorphisms in Type 2 Diabetes Mellitus

BMC Genomics
BiotechnologyGenetics
2014English

The Potential Role of Sodium Glucose Co-Transporter 2 Inhibitors in the Early Treatment of Type 2 Diabetes Mellitus

International Journal of Clinical Practice
Medicine
2015English

The Role of Bile Acid Sequestrants in the Management of Type 2 Diabetes Mellitus

Metabolic Syndrome and Related Disorders
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2014English

Novel Approaches to the Treatment of Hyperglycaemia in Type 2 Diabetes Mellitus

Internal Medicine Journal
Internal Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy